197 related articles for article (PubMed ID: 22377747)
1. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
[TBL] [Abstract][Full Text] [Related]
2. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
Mendu DR; Chou PP; Soldin SJ
Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650.
Stephen DW; Rooke P; Clark S; Coutts M; Crowe L; Docherty D
Ann Clin Biochem; 2003 Nov; 40(Pt 6):697-700. PubMed ID: 14629812
[TBL] [Abstract][Full Text] [Related]
4. Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost.
Shi X; Gao H; Li Z; Li J; Liu Y; Li L; Zhang Q
BMC Pharmacol Toxicol; 2019 Jan; 20(1):3. PubMed ID: 30626430
[TBL] [Abstract][Full Text] [Related]
5. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatography.
Slørdal L; Prytz PS; Pettersen I; Aarbakke J
Ther Drug Monit; 1986; 8(3):368-72. PubMed ID: 3529519
[TBL] [Abstract][Full Text] [Related]
7. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
8. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.
Guerriero E; Simon N; Nelken B; Baldeyrou B; Djobo B; Vasseur M; Allorge D; Décaudin B; Odou P
Ther Drug Monit; 2014 Aug; 36(4):499-504. PubMed ID: 25014075
[TBL] [Abstract][Full Text] [Related]
9. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
[TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate plasma pharmacokinetics: importance of assay method.
Eksborg S; Albertioni F; Rask C; Beck O; Palm C; Schroeder H; Peterson C
Cancer Lett; 1996 Nov; 108(2):163-9. PubMed ID: 8973590
[TBL] [Abstract][Full Text] [Related]
14. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
[TBL] [Abstract][Full Text] [Related]
15. Processing Validation Metrics of Syva Enzyme-Multiplied Immunoassay Technique (EMIT) Methotrexate Assay for Beckman Coulter System.
Nayak S; Patel S; Nanda R; Shah S; Mohapatra E
Cureus; 2023 Jan; 15(1):e34025. PubMed ID: 36814748
[TBL] [Abstract][Full Text] [Related]
16. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
Smith PF; Petros WP; Soucie MP; Copeland KR
Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
Charlier CJ; Plomteux GJ
Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
[TBL] [Abstract][Full Text] [Related]
19. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
20. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
Dias VC; Legatt DF; Yatscoff RW
Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]